Edward F. Mackey - 17 Feb 2022 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP, Operations
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 17 Feb 2022
Net transactions value: -$474,325
Form type: 4
Filing time: 22 Feb 2022, 15:44:57 UTC
Previous filing: 17 Feb 2022
Next filing: 23 Feb 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$0	+2,833	+8.7%	$0.000000	35,267	17 Feb 2022	Direct	F1
transaction	BSX	Common Stock	Tax liability	$35,635	-832	-2.4%	$42.83	34,435	17 Feb 2022	Direct
transaction	BSX	Common Stock	Options Exercise	$0	+23,719	+69%	$0.000000	58,154	18 Feb 2022	Direct	F2
transaction	BSX	Common Stock	Options Exercise	$0	+2,223	+3.8%	$0.000000	60,377	18 Feb 2022	Direct	F2
transaction	BSX	Common Stock	Tax liability	$438,690	-10,310	-17%	$42.55	50,067	18 Feb 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Restricted Stock Units	Options Exercise	$0	-2,833	-25%	$0.000000	8,500	17 Feb 2022	Common Stock	2,833		Direct	F1, F3
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-23,719	-100%	$0.000000^*	0	18 Feb 2022	Common Stock	23,719		Direct	F2, F4
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-2,223	-33%	$0.000000	4,448	18 Feb 2022	Common Stock	2,223		Direct	F2, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F2	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 17, 2022, the first anniversary of the date of grant.
F4	Shares of common stock will be issued to the reporting person in one installment on February 18, 2022, the second anniversary of the date of grant.
F5	Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 18, 2021, the first anniversary of the date of grant.